(Q52123569)

22 April 2018

title

clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma (English)

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

1 reference

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

author name string

D. C. Stolinsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

J. Solomon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

R. P. Pugh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

A. R. Stevens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

E. M. Jacobs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

L. E. Irwin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

D. A. Wood

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

J. L. Steinfeld

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

J. R. Bateman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4920400

20 March 2023

language of work or name

English

0 references

publication date

1 November 1970

1 reference

22 April 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

1 reference

22 April 2018

volume

26

1 reference

22 April 2018

issue

5

1 reference

22 April 2018

page(s)

984-990

1 reference

22 April 2018

A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197011%2926%3A5%3C984%3A%3AAID-CNCR2820260504%3E3.0.CO%3B2-E

The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide

21 January 2018

1

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

Monoamine oxidase inhibition by a new carcinostatic agent, N-isopropyl-a92-methylhydrazino)-p-toluamide (MIH).

20 March 2023

6

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

Use of a Methyl Hydrazine Derivative (Natulan®), Especially in Hodgkin's Disease

20 March 2023

8

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

Meaningful clinical classification of therapeutic responses to anticancer drugs

20 March 2023

9

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

13

26

1063

Lukes

1966

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA

20 March 2023

16

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

18

26

1310

Rosenberg

1966

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

Cytological investigations with a new class of cytotoxic agents. methylhydrazine derivatives

20 March 2023

19

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia

20 March 2023

20

1 reference

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

https://api.crossref.org/works/10.1002/1097-0142(197011)26:5%3C984::AID-CNCR2820260504%3E3.0.CO;2-E

20 March 2023

Identifiers

10.1002/1097-0142(197011)26:5<984::AID-CNCR2820260504>3.0.CO;2-E

1 reference

22 April 2018

1 reference

22 April 2018